Nuclear Medicine: Page 19

SPECT/CT AI model predicts major adverse cardiac events

By Will Morton

A deep-learning model developed for SPECT myocardial perfusion imaging could help clinicians identify patients at risk for major adverse cardiac events.

October 11, 2022

NorthStar signs deal with Eckert & Ziegler for hot cells

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has signed an agreement with Eckert & Ziegler Isotope Technologies Dresden for hot cells and related equipment to be used in NorthStar's construction of a production facility for noncarrier-added actinium-225 (Ac-225).

October 10, 2022

Telix highlights EANM presentations

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting presentations on the company's theranostics radiopharmaceuticals that will take place at the European Association of Nuclear Medicine (EANM) 2022 Congress, in Barcelona, Spain, October 15-19.

October 10, 2022

Clarity highlights first dosage of patient in prostate cancer trial

By AuntMinnie.com staff writers

Radiopharmaceutical developer Clarity Pharmaceuticals is highlighting the dosing of the first patient in the therapeutic phase of a clinical trial examining the effectiveness of the company's theranostic products.

October 6, 2022

Siemens installs first Biograph Vision Quadra PET/CT in North America

By AuntMinnie.com staff writers

Siemens Healthineers has installed its first Biograph Vision Quadra PET/CT scanner in North America at the Mayo Clinic in Rochester, MN.

October 2, 2022

SPECT tracers go head-to-head in prostate cancer patients

By Will Morton

More metastatic bone tumors can be diagnosed in patients with prostate cancer using SPECT/CT with an experimental radiotracer over standard methods, according to a study by Chinese researchers published September 26 in Scientific Reports.

September 27, 2022

Experts focus on expanding global radiation medicine capabilities

By Will Morton

Improving radiation medicine capabilities in poorer countries is key to bridging the massive global gap in cancer care, according to experts gathered this week during the International Atomic Energy Agency's 2022 Scientific Forum in Vienna.

September 27, 2022

Hermes Medical donates AI software to Regis College

By AuntMinnie.com staff writers

Sweden's Hermes Medical Solutions has donated molecular imaging artificial intelligence (AI) software to Regis College in Weston, MA, to help provide students a hands-on experience with the latest medical imaging technology in the field.

September 22, 2022

Isotopia inks deal to supply Lu-177 to Clovis Oncology

By AuntMinnie.com staff writers

Isotopia Molecular Imaging signed a two-year supply deal to provide Clovis Oncology with lutetium-177 (Lu-177).

September 20, 2022

Shine inks Lu-177 supply deal with Radiopharm Theranostics

By AuntMinnie.com staff writers

Shine Technologies has signed an agreement to supply Radiopharm Theranostics with noncarrier-added lutetium-177 (Lu-177).

September 19, 2022

NorthStar buys two additional accelerators from IBA

By AuntMinnie.com staff writers

NorthStar Medical Radioisotope has inked a deal to buy two more Rhodotron TT300 HE electron-beam accelerators and associated beamlines from Ion Beam Applications (IBA).

September 19, 2022

Does Tc-99m SPECT damage DNA?

By Will Morton

A common laboratory test called a "comet assay" shows that radiation from technetium-99m (Tc-99m) SPECT myocardial perfusion imaging poses little risk of damaging a patient's DNA, according to a Brazilian group.

September 19, 2022

Previous Page

Page 19 of 440

Next Page